Page last updated: 2024-12-11

2,3-oxidosqualene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3-oxidosqualene: an oxidized derivative of SQUALENE that can fold in several ways: chair-boat-chair-boat to LANOSTEROL; chair-chair-chair-boat to dammarane; or all chair to hopane and on to cycloartenol; RN given refers to (all-Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,3-epoxysqualene : A squalene triterpenoid obtained by formal epoxidation across the 2,3 C=C bond of squalene. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

oxidosqualene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(S)-2,3-epoxysqualene : A 2,3-epoxysqualene in which the chiral centre has S configuration. It is converted into lanosterol by lanosterol synthase (EC 5.4.99.7) in a key rate-limiting step in the biosynthesis of chloesterol, steroid hormones, and vitamin D. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5366020
CHEBI ID78662
SCHEMBL ID1009221
SCHEMBL ID1142772
SCHEMBL ID14640051
MeSH IDM0043576
PubMed CID5459811
CHEBI ID15441
SCHEMBL ID188732
MeSH IDM0043576

Synonyms (73)

Synonym
unii-2y5jjz8e4w
2,3-epoxy-2,3-dihydrosqualene
(3s)-oxidosqualene
7200-26-2
2y5jjz8e4w ,
squalene-2,3-oxide
squslene oxide
oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentamethyl-3,7,11,15,19-heneicosapentaenyl)-, (all-e)- (van)
squalene-2,3-epoxide
2,3-edsq
2,3-oxidosqualene
squalene peroxide
2,2-dimethyl-3-[(3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane
squalene oxide
SCHEMBL1009221
2,3-epoxysqualene
2,2-dimethyl-3-[(3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaen-1-yl]oxirane
CHEBI:78662
SCHEMBL1142772
2,2-dimethyl-3-[(3e,7e,11e,15e)-3,7,12,16,20-pentamethyl-3,7,11,15,19-henicosapentaenyl]oxirane #
oxirane, 2,2-dimethyl-3-(3,7,12,16,20-pentamethyl-3,7,11,15,19-heneicosapentaenyl)-, (all-e)-
SCHEMBL14640051
(6e,10e,14e,18e)-2,3-epoxy-2,6,10,15,19,23-epoxy-2,6,10,15,19,23-hexamethyl-6,10,14,18,22-tetracosapentaene
J39.259F ,
2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethyl-3,7,11,15,19-henicosapentaen-1-yl)oxirane
2,3-oxidosqualene, (all-e)-(+/-)-isomer
(rs)-2,3-epoxy-2,3-dihydrosqualene
(+/-)-squalene oxide
(r,s)-squalene 2,3-epoxide
oxirane, 2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethyl-3,7,11,15,19-heneicosapentaen-1-yl)-
2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethyl-3,7,11,15,19-henicosapentenyl)oxirane
2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl)oxirane
(3r,s)-oxidosqualene
(6e,10e,14e,18e)-2,3-epoxy-2,6,10,15,19,23-hexamethyl-6,10,14,18,22-tetracosapentaene
(6e,10e,14e,18e)-22,23-epoxy-2,6,10,15,19,23-hexamethyl-2,6,10,14,18-tetracosapentene
squalene epoxide
2,6,10,14,18-tetracosapentaene, 22,23-epoxy-2,6,10,15,19,23-hexamethyl-, (all-e)-
(+/-)-2,3-epoxysqualene
2,3-oxidosqualene, >=92.0% (hplc)
2,2-dimethyl-3-(3,7,12,16,20-pentamethyl-3,7,11,15,19-heneicosapentaenyl)oxirane
DTXSID50900960
Q2080986
PD163922
3(s)-oxidosqualene
2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaen-1-yl)oxirane
(3s)-2,2-dimethyl-3-[(3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaen-1-yl]oxirane
(s)-2,3-oxidosqualene
(s)-2,3-dihydro-2,3-epoxysqualene
(3s)-2,3-dihydro-2,3-epoxysqualene
CHEBI:15441
(s)-2,3-epoxy-2,3-dihydrosqualene
2,3-epoxisqualene
(3s)-2,3-epoxysqualene
9029-62-3
(3s)-2,3-epoxy-2,3-dihydrosqualene
squalene 2,3-epoxide
(s)-squalene-2,3-epoxide
(s)-2,3-epoxysqualene
C01054
squalene 2,3-oxide
oxidosqualene
(3s)-2,2-dimethyl-3-[(3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane
3s-squalene-2,3-epoxide
2,3s-epoxy-2,6,10,15,19,23-hexamethyltetracosa-6e,10e,14e,18e,22-pentaene
LMPR0106010010
(3s)-2,2-dimethyl-3-[(7e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane
gtpl6551
SCHEMBL188732
(3s)-2,3-oxidosqualene, >=97.5% (hplc)
54910-48-4
(s)-2,2-dimethyl-3-((3e,7e,11e,15e)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaen-1-yl)oxirane
Q27453274
STARBLD0002330

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The extract of Catuaba (Anemopaegma mirandum) prevented these toxic effects with the main active agents suggested to be cinchonains IIa and IIb."( Potent protecting effects of Catuaba (Anemopaegma mirandum) extracts against hydroperoxide-induced cytotoxicity.
Ando, M; Kawahara, N; Saito, Y; Satake, M; Sekita, S; Tokunaga, H; Uchino, T, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
squalene triterpenoidA triterpenoid based on a squalene skeleton and its substituted derivatives thereof.
2,3-epoxysqualeneA squalene triterpenoid obtained by formal epoxidation across the 2,3 C=C bond of squalene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (48)

PathwayProteinsCompounds
Cholesterol biosynthesis pathway in hepatocytes1137
Metabolism14961108
Metabolism of lipids500463
Metabolism of steroids111135
Cholesterol biosynthesis2249
marneral biosynthesis04
soybean saponin I biosynthesis316
avenacin biosynthesis, initial reactions23
mangrove triterpenoid biosynthesis77
lanosterol biosynthesis12
superpathway of avenacin A biosynthesis615
(3E)-4,8-dimethylnona-1,3,7-triene biosynthesis II15
thalianol and derivatives biosynthesis04
baruol biosynthesis02
oleanolate biosynthesis38
ginsenosides biosynthesis225
avenacin A-1 biosynthesis310
u03B1-amyrin biosynthesis12
glycyrrhetinate biosynthesis28
lupeol biosynthesis22
Steroids metabolism ( Steroids metabolism )1627
(S)-2,3-Epoxy-squalene = Lanosterol ( Steroids metabolism )12
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways039
superpathway of ergosterol biosynthesis II133
cholesterol biosynthesis I428
parkeol biosynthesis12
cycloartenol biosynthesis72
epoxysqualene biosynthesis29
plant sterol biosynthesis II519
pentacyclic triterpene biosynthesis210
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
Cholesterol synthesis disorders015
Cholesterol metabolism214
Enterocyte cholesterol metabolism111
Ergosterol biosynthesis332
epoxysqualene biosynthesis912
superpathway of ergosterol biosynthesis II135
superpathway of ergosterol biosynthesis I2156
ergosterol biosynthesis II116
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)937
cholesterol biosynthesis I944
lanosterol biosynthesis33
cholesterol biosynthesis III (via desmosterol)939
7-dehydroporiferasterol biosynthesis118
superpathway of cholesterol biosynthesis2178
(3E)-4,8-dimethylnona-1,3,7-triene biosynthesis II25
plant sterol biosynthesis1652
diploterol and cycloartenol biosynthesis27
marneral biosynthesis14
pentacyclic triterpene biosynthesis1411
ginsenosides biosynthesis1032
soybean saponin I biosynthesis516
baruol biosynthesis12
oleanolate biosynthesis48
glycyrrhetinate biosynthesis213
lupeol biosynthesis02
thalianol and derivatives biosynthesis24
superpathway of ergosterol biosynthesis2256
superpathway of sterol biosynthesis050
Cholesterol biosynthesis01
Cholesterol biosynthesis pathway02
Biochemical pathways: part I0466
Sterol biosynthesis525
Cholesterol biosynthesis I118
Cholesterol biosynthesis II (via 24,25-dihydrolanosterol)117
Cholesterol biosynthesis III (via desmosterol)118

Research

Studies (123)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (11.38)18.7374
1990's17 (13.82)18.2507
2000's34 (27.64)29.6817
2010's42 (34.15)24.3611
2020's16 (13.01)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.91 (24.57)
Research Supply Index4.57 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews5 (5.21%)6.00%
Reviews4 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other91 (94.79%)84.16%
Other30 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]